Table 1.
Clinical features of febrile patients with hematological malignancies
| Demographic/characteristic | No. patients (%) (n = 72) |
|---|---|
| Age (years) |
|
| Median |
42.5 |
| Range |
3–76 |
| Gender |
|
| Male |
42 (58.3) |
| Female |
30 (41.7) |
| Hematological malignancy |
|
| AML |
30 (41.7) |
| ALL |
10 (13.9) |
| CML |
3 (4.2) |
| CMML |
1 (1.4) |
| CLL |
2 (2.8) |
| NHL |
14 (19.4) |
| MDS |
7 (9.7) |
| MM |
5 (6.9) |
| HSCT |
25 (34.7) |
| Allo-HSCT |
21 (29.2) |
| Auto-HSCT |
4 (5.6) |
| IA |
41 (56.9) |
| Proven |
4 (5.6) |
| Probable |
18 (25) |
| Possible |
19 (26.4) |
| Sites |
|
| Pulmonary |
40 (55.6) |
| Systemic | 1 (1.4) |
AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; CML, chronic myelogenous leukemia; CMML, chronic myelomonocytic leukemia; CLL, chronic lymphocytic leukemia; NHL, non-Hodgkin’s lymphoma; MDS, myelodysplastic syndromes; MM, multiple myeloma; HSCT, hematopoietic stem cell transplantation; IA, invasive aspergillosis.